Literature DB >> 25681083

Developmental Outcomes of School-Age Children with Duarte Galactosemia: A Pilot Study.

Mary Ellen Lynch1, Nancy L Potter, Claire D Coles, Judith L Fridovich-Keil.   

Abstract

Duarte galactosemia (DG) is a mild allelic variant of classic galactosemia that results from partial impairment of galactose-1P uridylyltransferase (GALT). Although infants with DG are detected by newborn screening in some US states at close to 1/4,000 live births, most are discharged from follow-up very early in life and there is no consensus on whether these children are at increased risk for any of the long-term developmental delays seen in classic galactosemia. There is also no consensus on whether infants with DG benefit from dietary restriction of galactose. Reflecting the current uncertainty, some states choose to identify infants with DG by newborn screening and others do not. As a first step toward characterizing the developmental outcomes of school-age children with DG, we conducted a pilot study, testing 10 children with DG and 5 unaffected siblings from the same group of families. All children tested were between 6 and 11 years old. We used standardized direct assessments and parent-response surveys to collect information regarding cognition, communication, socio-emotional, adaptive behavior, and physical development for each child. Despite the small sample size, our data demonstrated some notable differences between cases and controls in socio-emotional development, in delayed recall, and in auditory processing speed. These results confirm that direct assessment of school-age children with DG can detect subtle but potentially problematic developmental deficits, and underscore the need for a larger study which has sufficient power to evaluate these outcomes while controlling for potentially confounding factors.

Entities:  

Year:  2015        PMID: 25681083      PMCID: PMC4501238          DOI: 10.1007/8904_2014_370

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  13 in total

1.  The neuropsychological profile of galactosaemia.

Authors:  Claire M Doyle; Shelley Channon; Danuta Orlowska; Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

2.  Maturational changes in auditory transmission as reflected in human brain stem potentials.

Authors:  A Salamy; C M McKean; F B Buda
Journal:  Brain Res       Date:  1975-10-17       Impact factor: 3.252

3.  Motor and speech disorders in classic galactosemia.

Authors:  Nancy L Potter; Yves Nievergelt; Lawrence D Shriberg
Journal:  JIMD Rep       Date:  2013-04-02

4.  Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study.

Authors:  Kevin M Antshel; Ingrid O Epstein; Susan E Waisbren
Journal:  Neuropsychology       Date:  2004-10       Impact factor: 3.295

5.  The adult galactosemic phenotype.

Authors:  Susan E Waisbren; Nancy L Potter; Catherine M Gordon; Robert C Green; Patricia Greenstein; Cynthia S Gubbels; Estela Rubio-Gozalbo; Donald Schomer; Corrine Welt; Vera Anastasoaie; Kali D'Anna; Jennifer Gentile; Chao-Yu Guo; Leah Hecht; Roberta Jackson; Bernadette M Jansma; Yijun Li; Va Lip; David T Miller; Michael Murray; Leslie Power; Nicolle Quinn; Frances Rohr; Yiping Shen; Amy Skinder-Meredith; Inge Timmers; Rachel Tunick; Ann Wessel; Bai-Lin Wu; Harvey Levy; Louis Elsas; Gerard T Berry
Journal:  J Inherit Metab Dis       Date:  2011-07-21       Impact factor: 4.982

6.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

7.  The impact of maternal smoking on fast auditory brainstem responses.

Authors:  Julie A Kable; Claire D Coles; Mary Ellen Lynch; Julie Carroll
Journal:  Neurotoxicol Teratol       Date:  2009-02-27       Impact factor: 3.763

8.  Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening.

Authors:  Can Ficicioglu; Nina Thomas; Claire Yager; Paul R Gallagher; Christie Hussa; Andrea Mattie; Debra L Day-Salvatore; Brian J Forbes
Journal:  Mol Genet Metab       Date:  2008-10-30       Impact factor: 4.797

9.  Correlates of language impairment in children with galactosaemia.

Authors:  N L Potter; J-A C Lazarus; J M Johnson; R D Steiner; L D Shriberg
Journal:  J Inherit Metab Dis       Date:  2008-07-12       Impact factor: 4.982

10.  Long-term speech and language developmental issues among children with Duarte galactosemia.

Authors:  Kimberly K Powell; Kim Van Naarden Braun; Rani H Singh; Stuart K Shapira; Richard S Olney; Marshalyn Yeargin-Allsopp
Journal:  Genet Med       Date:  2009-12       Impact factor: 8.822

View more
  2 in total

1.  Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marzia Pasquali; Chunli Yu; Bradford Coffee
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

2.  Pilot study of classic galactosemia: Neurodevelopmental impact and other complications urge neonatal screening in Egypt.

Authors:  Magd A Kotb; Lobna Mansour; Christine William Shaker Basanti; Wael El Garf; Ghada I Z Ali; Sally T Mostafa El Sorogy; Inas E M Kamel; Naglaa M Kamal
Journal:  J Adv Res       Date:  2018-02-23       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.